HER2-positive breast cancer targeting and treatment by a peptide-conjugated mini nanodrug

HER2+ breast cancer is one of the most aggressive forms of breast cancer. The new polymalic acid-based mini nanodrug copolymers are synthesized and specifically characterized to inhibit growth of HER2+ breast cancer. These mini nanodrugs are highly effective and in the clinic may substitute for tras...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Nanomedicine
Asıl Yazarlar: Ding, Hui, Gangalum, Pallavi R., Galstyan, Anna, Fox, Irving, Patil, Rameshwar, Hubbard, Paul, Murali, Ramachandran, Ljubimova, Julia Y., Holler, Eggehard
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5812454/
https://ncbi.nlm.nih.gov/pubmed/27520726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.07.013
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller